Glycopyrrolate exerts medium-duration bronchodilator activity in guinea-pig and human airways

G. Villetti, M. Bergamaschi, F. Bassani, P. T. Bolzoni, S. Harrison, P. M. Gigli, A. Ianni, M. Civelli, P. Geppetti, R. Patacchini (Parma, Florence, Italy)

Source: Annual Congress 2005 - New perspectives in asthma treatment
Session: New perspectives in asthma treatment
Session type: Poster Discussion
Number: 1402
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Villetti, M. Bergamaschi, F. Bassani, P. T. Bolzoni, S. Harrison, P. M. Gigli, A. Ianni, M. Civelli, P. Geppetti, R. Patacchini (Parma, Florence, Italy). Glycopyrrolate exerts medium-duration bronchodilator activity in guinea-pig and human airways. Eur Respir J 2005; 26: Suppl. 49, 1402

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The dual PDE3/PDE4 phosphodiesterase inhibitor RPL554 produces more complete bronchodilator responses than the beta2-agonist salbutamol and the anti-muscarinic agent ipratropium bromide, alone and in combination, in guinea-pig isolated trachea
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015


The long-acting β2-agonist formoterol re-establishes the anti-proliferative effect of glucocorticoids in asthmatic airway smooth muscle cells (ASMC)
Source: Annual Congress 2011 - Understanding disease and drug mechanisms
Year: 2011



The inhaled anticholinergic agent, aclidinium bromide, reverses cholinergic-induced bronchoconstriction in guinea pigs with a fast onset of action and a long duration of effect
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008


Budesonide prevents cytokine-induced decrease of the relaxant response to formoterol but not to salmeterol in mouse trachea
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009


Budesonide reverses IL-13–induced airway hyper-responsiveness but has little effect on β2 agonist response in human small airways
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012

Synergistic effects between glycopyrronium bromide and indacaterol on a muscarinic agonist-induced contraction in airway smooth muscle
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012


Synergistic bronchoprotective activity of the long-acting beta 2-agonist olodaterol with tiotropium (long-acting M3 antagonist) and ciclesonide (inhaled steroid) on the ovalbumin-induced bronchoconstriction in anaesthetized guinea pigs
Source: Annual Congress 2011 - Understanding disease and drug mechanisms
Year: 2011


Rapid inhibitory effects of budesonide and formoterol on bradykinin-induced Ca2+ mobilization in human lung fibroblasts
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

Budesonide augments formoterol-induced bronchodilation of human small airways within minutes
Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Year: 2015


Bronchial hypersensitivity and acute bronchodilatory effect of salbutamol on methacholine-induced bronchoconstriction in asthmatics with excessive airway narrowing
Source: Eur Respir J 2004; 24: Suppl. 48, 442s
Year: 2004

Inhaled roflumilast and tadalafil supress airway reactivity and inflammation in ovalbumin-sensitized guinea pigs
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016

Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016

Protective effect of inhaled iloprost on exercise-induced bronchoconstriction
Source: Eur Respir J 2004; 24: Suppl. 48, 443s
Year: 2004

Effects of salbutamol enantiomers on equine isolated bronchial airways
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009

Pharmacological interaction between glycopyrronium bromide and indacaterol fumarate on the human airways tone
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016

Compound X – an inhaled β2 agonist with equivalent potency and superior duration of action (DOA)/ therapeutic index (TI) to salmeterol in the anaesthetised dog model of bronchoconstriction
Source: Annual Congress 2008 - Novel treatments for respiratory disease
Year: 2008

Modulation of cholinergic contractions of airway smooth muscle by cathinone: potential beneficial effects in airway diseases
Source: Eur Respir J 2008; 32: 579-584
Year: 2008



Involvement of the BK channels/G proteins processes in the synergistic effects between anticholinergic agents and beta2-adrenoceptor agonists in airway smooth muscle
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013


The influence of epithelium on the effect of isoprenaline incubation in responsiveness of guinea-pig trachea to b-adrenergic agonist and antagonist
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III
Year: 2007


Antagonism by reproterol of adenosine-mediated tension responses in isolated guinea pig trachea
Source: Eur Respir J 2003; 22: Suppl. 45, 106s
Year: 2003